A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase.
New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability may contribute to the development of severe, and sometimes fatal, diseases.
The study, published in Science, offers new clues for identifying mutations in this protein that could help doctors screen for certain cancers and disorders affecting bone marrow.
Chromosomes (bundles of proteins and DNA that hold our genetic blueprint) are shielded from damage by telomeres, the protective caps made of repeating DNA sequences and proteins at each chromosome's end. Although telomeres naturally shorten as we age, disruptions in how they are formed or maintained can destabilize DNA, potentially triggering premature aging and disease.
Researchers in the laboratory of Ci Ji Lim, a biochemistry professor at UW–Madison, worked with colleagues in the university's Department of Chemistry to search for proteins that interact with telomerase, the enzyme that maintains telomeres. They suspected that defects in these associated proteins might contribute to certain illnesses that arise when telomeres become abnormally short.
"This line of research goes beyond a biochemical understanding of a molecular process. It deepens clinical understanding of telomere diseases," says Lim, whose work is supported by the National Institutes of Health.
Discovering RPA's Hidden Role
The researchers, led by graduate student Sourav Agrawal, research scientist Xiuhua Lin, and postdoctoral researcher Vivek Susvirkar, searched for proteins likely to interact with telomerase using AlphaFold, a machine learning tool that predicts the 3D structure of proteins and protein-protein interactions. They found that a molecule called replication protein A (RPA) plays an essential role in maintaining telomeres by stimulating telomerase. RPA's role in DNA replication and repair has long been understood, but its role in maintaining long, healthy telomeres in humans was previously unconfirmed. Guided by their findings from AlphaFold, the team experimentally validated that, in humans, RPA is required to stimulate telomerase and help maintain telomeres.
Their findings, Lim says, have immediate implications for some patients with often fatal illnesses resulting from shortened telomeres, including aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia.
"There are some patients with shortened telomere disorders that couldn't be explained with our previous body of knowledge," explains Lim. "Now we have an answer to the underlying cause of some of these short telomere disease mutations: it is a result of RPA not being able to stimulate telomerase."
A Global Impact and Future Testing
Lim and his team have received inquiries from clinicians and scientists around the world asking if their patients' diseases could be the result of genetic mutations inhibiting RPA's newfound function.
"There are colleagues reaching out from France, Israel, and Australia. They just want to give a cause for their patients' short telomere disease so that the patients and their families can understand what is happening and why," says Lim. "With biochemical analysis, we can test their patients' mutation to see if it impacts how RPA interacts with telomerase, and give the doctors insights into possible causes of their patients' diseases."
Reference: "Human RPA is an essential telomerase processivity factor for maintaining telomeres" by Sourav Agrawal, Xiuhua Lin, Vivek Susvirkar, Michael S. O'Connor, Bianca L. Chavez, Victoria R. Tholkes, Grace P. Tauber, Qixiang He, Kaitlyn M. Abe, Xuhui Huang and Ci Ji Lim, 30 October 2025, Science.
DOI: 10.1126/science.ads5297
This research was funded in part by the National Institutes of Health (R01GM153806 and DP2GM150023), the UW–Madison Office of the Vice Chancellor for Research, the Wisconsin Alumni Research Foundation and UW–Madison Department of Biochemistry.
News
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
